Search by Drug Name or NDC

    NDC 70436-0198-06 Diltiazem Hydrochloride 300 mg/1 Details

    Diltiazem Hydrochloride 300 mg/1

    Diltiazem Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals, LLC. The primary component is DILTIAZEM HYDROCHLORIDE.

    Product Information

    NDC 70436-0198
    Product ID 70436-198_0bf763a5-e281-7ec0-e063-6294a90a0930
    Associated GPIs
    GCN Sequence Number 051804
    GCN Sequence Number Description diltiazem HCl TAB ER 24H 300 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 19185
    HICL Sequence Number 000182
    HICL Sequence Number Description DILTIAZEM HCL
    Brand/Generic Generic
    Proprietary Name Diltiazem Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Diltiazem Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name DILTIAZEM HYDROCHLORIDE
    Labeler Name Slate Run Pharmaceuticals, LLC
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216439
    Listing Certified Through 2024-12-31

    Package

    NDC 70436-0198-06 (70436019806)

    NDC Package Code 70436-198-06
    Billing NDC 70436019806
    Package 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-198-06)
    Marketing Start Date 2023-03-20
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.40804
    Pricing Unit EA
    Effective Date 2023-09-20
    NDC Description DILTIAZEM 24H ER(LA) 300 MG TB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis